수두 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Chickenpox Vaccine Trends and Forecast

The future of the global chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets. The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines, and growing government contribution in immunization programs.

A more than 150-page report is developed to help in your business decisions.

Chickenpox Vaccine by Segment

The study includes a forecast for the global chickenpox vaccine by product type, application, end use, and region.

Chickenpox Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent Varicella Vaccine
• Combination Varicella Vaccine

Chickenpox Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Mumps
• Measles
• Rubella
• Varicella Immunization
• Herpes Zoster
• Immunization
• Chickenpox Vaccination

Chickenpox Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Others

Chickenpox Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Chickenpox Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chickenpox vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chickenpox vaccine companies profiled in this report include-

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

Chickenpox Vaccine Market Insights

Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Within this market, hospital is expected to witness higher growth over the forecast period.

North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Features of the Global Chickenpox Vaccine Market

Market Size Estimates: Chickenpox vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chickenpox vaccine market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Chickenpox vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the chickenpox vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chickenpox vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the chickenpox vaccine market size?

Answer: The global chickenpox vaccine market is expected to reach an estimated $4.6 billion by 2030.

Q.2 What is the growth forecast for chickenpox vaccine market?

Answer: The global chickenpox vaccine market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the chickenpox vaccine market?

Answer: The major drivers for this market are increasing number of vaccination programs throughout the world, rising public awareness of the use of chickenpox vaccines and growing government contribution in immunization programs.

Q4. What are the major segments for chickenpox vaccine market?

Answer: The future of the chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key chickenpox vaccine market companies?

Answer: Some of the key chickenpox vaccine companies are as follows:

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

Q6. Which chickenpox vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that herpes zoster is expected to witness highest growth over the forecast period.

Q7. In chickenpox vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to presence of well-established vaccination program and growing demand for vaccine coverage rate with expanding population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the chickenpox vaccine market by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chickenpox Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Chickenpox Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Chickenpox Vaccine Market by Product Type
  • 3.3.1: Monovalent Varicella Vaccine
  • 3.3.2: Combination Varicella Vaccine
• 3.4: Global Chickenpox Vaccine Market by Application
  • 3.4.1: Mumps
  • 3.4.2: Measles
  • 3.4.3: Rubella
  • 3.4.4: Varicella Immunization
  • 3.4.5: Herpes Zoster
  • 3.4.6: Immunization
  • 3.4.7: Chickenpox Vaccination
• 3.5: Global Chickenpox Vaccine Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Chickenpox Vaccine Market by Region
• 4.2: North American Chickenpox Vaccine Market
  • 4.2.1: North American Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.2.2: North American Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
• 4.3: European Chickenpox Vaccine Market
  • 4.3.1: European Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.3.2: European Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
• 4.4: APAC Chickenpox Vaccine Market
  • 4.4.1: APAC Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.4.2: APAC Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others
• 4.5: ROW Chickenpox Vaccine Market
  • 4.5.1: ROW Chickenpox Vaccine Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.5.2: ROW Chickenpox Vaccine Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Chickenpox Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Chickenpox Vaccine Market by Application
  • 6.1.3: Growth Opportunities for the Global Chickenpox Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Chickenpox Vaccine Market by Region
• 6.2: Emerging Trends in the Global Chickenpox Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Chickenpox Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chickenpox Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bio-Med
• 7.2: GlaxoSmithKline
• 7.3: Emcure Pharmaceuticals
• 7.4: Novo Medi Services
• 7.5: Sanofi
• 7.6: Takeda Pharmaceutical
• 7.7: Changchun BCHT Biotechnology
• 7.8: Green Cross Holdings
• 7.9: Merck
• 7.10: Mitsubishi Chemical Holdings